logo
logo

Xencor Appoints Bart Cornelissen As Senior Vice President and Chief Financial Officer

Apr 09, 2024over 1 year ago

Position

Chief Financial Officer

Company

Xencor

Bart Cornelissen
PasadenaBiopharmaTherapeuticsBiotechnologyHealth Care

Description

Xencor, Inc. announced the appointment of Bart Cornelissen to senior vice president and chief financial officer. Mr

Company Information

Company

Xencor

Location

Pasadena, California, United States

About

Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months